Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

Chen, Chang; Zhang, Yi; Huang, Jianying; Yin, Ping; Cheng, Zhenshun; Wu, Jianyuan; Chen, Song; Zhang, Yongxi; Chen, Bo; Lü, Mengxin; Luo, Yongwen; Ju, Lingao; Zhang, Jingyi; Wang, Xinghuan

doi:10.1101/2020.03.17.20037432

Public

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

Published in medRxiv • Mar 20, 2020

Authors:

Chang Chen

Yi Zhang

Jianying Huang

Abstract

Abstract Background No clinically proven effective antiviral strategy exists for the epidemic Coronavirus Disease 2019 (COVID-19). Methods We conducted a prospective, randomized, controlled, open-label multicenter trial involving adult patients with COVID-19. Patients were randomly assigned in a 1:1...

Subject

Favipiravir

Medicine

Adverse effect

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!